News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Kalderos

Advertisement

Articles by Kalderos

Understanding the impact of the Inflation Reduction Act on stakeholders in drug discount programs

ByKalderos
December 13th 2022

Understanding the impact Inflation Reduction Act on stakeholders in drug discount programs

ByKalderos
December 1st 2022

Understanding the Changes to Discarded Drug Refunds in Medicare Part B

ByKalderos
June 10th 2022
Discarded Drug Refunds in Medicare Part B: What Drug Manufacturers, Providers and Payers Need to Know

Discarded Drug Refunds in Medicare Part B: What Drug Manufacturers, Providers and Payers Need to Know

ByKalderos
March 22nd 2022

Tuesday, March 22, 2022 11 am CST | 12pm EST | 9am PT | 5pm GMT | 6pm CET There’s less than a year to operationalize discarded drug refunds in Medicare Part B. But with the proper planning and a smart, data-driven approach, your team can minimize implementation challenges and ensure compliant participation.

Advertisement

Latest Updated Articles

  • Understanding the impact Inflation Reduction Act on stakeholders in drug discount programs
    Understanding the impact Inflation Reduction Act on stakeholders in drug discount programs

    Published: December 1st 2022 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion

2

Strive Pharmacy Breaks Ground on Arizona HQ

3

What MFN Pricing Means for Future Drug Development

4

Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics

5

Pharma Pulse: New CDER Director Appointed, as Medicaid Shows Potential to Save Cancer Lives

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us